Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Health-Related Quality of Life in Adults Treated with Blinatumomab Using the Acute Lymphoblastic Leukemia Symptom Scale

Max S. Topp, MD, Zachary F. Zimmerman, MD PhD, Paul Cannell, MD, Herve Dombret, MD, Anthony S. Stein, MD, Janet Franklin, MD MPH, Kun Nie, PhD, Ze Cong, PhD, Andre Schuh, MD FRCPC

Blood (2017) 130 (Supplement 1): 2571.

https://doi.org/10.1182/blood.V130.Suppl_1.2571.2571

Published: 2017

Journal Articles

The Utility of Early Broncholaveolar Lavage in Prolonged Neutropenic Patients with Pulmonary Nodules

Dina Khalaf, MD BSc, Steven M. Chan, MD PhD, Vikas Gupta, MD PhD, Andrzej Lutynski, MD, Dawn Maze, MD FRCPC, MSc, Mark D. Minden, MD PhD, Yoichiro Natori, MD, Rhea Pavan, BA, Amr Rostom, MD, Anna Rydlewski, MD, Aaron Schimmer, MD PhD, Andre Schuh, MD FRCPC, Hassan Sibai, MBBS, Karen W.L. Yee, MD, Shahid Husain, MD MS

Blood (2017) 130 (Supplement 1): 4682.

https://doi.org/10.1182/blood.V130.Suppl_1.4682.4682

Published: 2017

Journal Articles

Migration in the Management of Philadelphia Positive ALL: Towards a Lower Risk of VTE

Hassan Sibai, MBBS, Maria Zigas, Arjun Datt Law, MBBS, MD DM, Umberto Falcone, MD, Solaf Sami Kanfar, MD, Naoko Sakurai, Vikas Gupta, MD PhD, Andre Schuh, MD FRCPC, Karen W.L. Yee, MD, Aaron Schimmer, MD PhD, Mark D. Minden, MD PhD, Dawn Maze, MD FRCPC, MSc, Steven M. Chan, MDPhD, Jack Seki, PharmD

Blood (2017) 130 (Supplement 1): 1283.

https://doi.org/10.1182/blood.V130.Suppl_1.1283.1283

Published: 2017

Journal Articles

Azacitidine Has Limited Activity in Patients with MDS and AML

Karen Yee, MD, Symron Bansal, Joseph Brandwein, MD, Mark D. Minden, MD, Aaron Schimmer, MD, PhD, Vikas Gupta, MD, FRCP, FRCPath, Arsenia Dharman, Christine Cserti-Gazdewich, MD, Andre Schuh, MD, FRCPC

Blood (2011) 118 (21): 5057.

https://doi.org/10.1182/blood.V118.21.5057.5057

Published: 2011

Journal Articles

An Evaluation of Septicemia During Outpatient Consolidation Chemotherapy for Acute Myeloid Leukemia

Lalit Saini, MD, Mark D. Minden, MD, PhD, Andre Schuh, MD, Karen Yee, MD, Aaron D Schimmer, MD, PhD, Vikas Gupta, MD, FRCP, FRCPath, Cindy Susan Murray, Joseph Brandwein, MD

Blood (2011) 118 (21): 4268.

https://doi.org/10.1182/blood.V118.21.4268.4268

Published: 2011

Journal Articles

A Phase I Study of ENMD-2076 In Patients with Relapsed or Refractory Leukemia

Karen W.L. Yee, MD, Hsaio-Wei Tina Chen, Joseph Brandwein, MD, FRCPC, Sue Chow, Deborah Sanfelice, David Hedley, MD, Vikas Gupta, MD, MRCP, FRCPath, Aaron Schimmer, MD, PhD, Carolyn Fowler Sidor, MD, Graham Fletcher, Jamie Arnott, Mark Bray, Mark D. Minden, MD, PhD, Andre Schuh, MD, FRCPC

Blood (2010) 116 (21): 3307.

https://doi.org/10.1182/blood.V116.21.3307.3307

Published: 2010

Journal Articles

A Prognostic Score of Overall Survival In Adults with Acute Myeloid Leukemia

Murtadha K. Al-Khabori, MD, FRCPC, Gordon Guyatt, MD, FRCPC, Mark D. Minden, MD, PhD, Karen Yee, MD, Vikas Gupta, MD, MRCP, FRCPath, Aaron Schimmer, MD, PhD, Andre Schuh, MD, FRCPC, Joseph Brandwein, MD, FRCPC

Blood (2010) 116 (21): 2730.

https://doi.org/10.1182/blood.V116.21.2730.2730

Published: 2010

Journal Articles

Validation of Monosomal Karyotype Based Model In the Risk Stratification of Acute Myeloid Leukemia

Murtadha K. Al-Khabori, MD, FRCPC, Karen Yee, MD, Vikas Gupta, MD, MRCP, FRCPath, Aaron Schimmer, MD, PhD, Andre Schuh, MD, FRCPC, Mark D. Minden, MD, PhD, Joseph Brandwein, MD, FRCPC

Blood (2010) 116 (21): 2745.

https://doi.org/10.1182/blood.V116.21.2745.2745

Published: 2010

Journal Articles

Low-Level FLT3-ITD Mutations Do Not Predict for Higher Relapse Rate in AML with Standard Risk Karyotpye.

Richard Ward, BSc, MRCP, FRCPath, Suzanne Kamel-Reid, PhD, FACMG, Wei Xu, PhD, Mark D. Minden, MD, PhD, Aaron D. Schimmer, MD, PhD, Karen WL Yee, MD, Andre Schuh, MD, Vikas Gupta, MD, Joseph Brandwein, MD

Blood (2009) 114 (22): 1591.

https://doi.org/10.1182/blood.V114.22.1591.1591

Published: 2009

Journal Articles

Feasibility of Outpatient Consolidation Chemotherapy and Toxicity in Elderly Patients with AML.

Richard Ward, BSc, MRCP, FRCPath, Vikas Gupta, MD, Mark D. Minden, MD, PhD, Aaron D. Schimmer, MD, PhD, Karen WL Yee, MD, Andre Schuh, MD, Wei Xu, PhD, Joseph Brandwein, MD

Blood (2009) 114 (22): 1036.

https://doi.org/10.1182/blood.V114.22.1036.1036

Published: 2009

Journal Articles

Lack of Inhibition of AKT Predicts Clinical Resistance to Therapy with Imatinib + Reinduction Chemotherapy in Relapsed/Refractory c-Kit+ Acute Myeloid Leukemia.

Joseph Brandwein, MD, David Hedley, MD, Sue Chow, Aaron D. Schimmer, MD, PhD, Karen WL Yee, Andre Schuh, MD, Vikas Gupta, Mark D. Minden, MD, PhD

Blood (2009) 114 (22): 2073.

https://doi.org/10.1182/blood.V114.22.2073.2073

Published: 2009

Journal Articles

Outcome of Patients Age 60 and Over with Acute Lymphoblastic Leukemia (ALL) Treated with a Modified Pediatric Protocol

Susan Kao, MD, Wei Xu, PhD, Vikas Gupta, MD, MRCP, MRCPath, Mark Minden, Andre Schuh, MD, Aaron D. Schimmer, Karen WL Yee, Joseph Brandwein, MD, FRCPC

Blood (2008) 112 (11): 3962.

https://doi.org/10.1182/blood.V112.11.3962.3962

Published: 2008

Journal Articles

A Phase I Trial of the Small Molecule Pan-Bcl-2 Family Inhibitor Obatoclax Mesylate (GX15-070) Administered by Continuous Infusion for up to Four Days to Patients with Hematological Malignancies.

Aaron D. Schimmer, MD, Joseph Brandwein, MD, Susan M. O’Brien, MD, Hagop Kantarjian, MD, Bruce D. Cheson, MD, Mark D. Minden, MD, Karen Yee, MD, Andre Schuh, MD, Vikas Gupta, MD, Jean Viallet, MD, Gautam Borthakur, MD

Blood (2007) 110 (11): 892.

https://doi.org/10.1182/blood.V110.11.892.892

Published: 2007

Journal Articles

A Phase I Trial of Two Sequence-Specific Schedules of Decitabine and Vorinostat in Patients with Acute Myeloid Leukemia (AML).

Karen W.L. Yee, MD, Mark D. Minden, MD, Joseph Brandwein, MD, Aaron Schimmer, MD, Andre Schuh, MD, Vikas Gupta, MD, Hans A. Messner, MD, Ronan Foley, MD, Parveen Wasi, MD, James A. Zwiebel, MD, Brian Leber, MD

Blood (2007) 110 (11): 908.

https://doi.org/10.1182/blood.V110.11.908.908

Published: 2007

Journal Articles

Nuclear Localization of the NuMA-RARα/RXRα Complex Is Necessary for Leukemogenesis in hCG-NuMA-RAR α Transgenic Mice.

Mahadeo A. Sukhai, BSc, MSc, Mariam Thomas, BSc, Yali Xuan, BSc, Soheila A. Hamadanizadeh, BSc, MSc, Rikki R. Bharadwaj, BSc, MSc, Andre Schuh, MD, Richard A. Wells, MD, DPhil, Suzanne Kamel-Reid

Blood (2006) 108 (11): 1403.

https://doi.org/10.1182/blood.V108.11.1403.1403

Published: 2006

Journal Articles

Small-Molecule XIAP Inhibitors Derepress Downstream Effector Caspases and Induce Apoptosis of Leukemia Cell Lines and Patient Samples.

Aaron D. Schimmer, MD, PhD, Marcela Gronda, MSc, Zhiliang Wang, PhD, Kate Welsh, PhD, Clemencia Pinilla, PhD, Michael Andreeff, MD, PhD, Wendy D. Schober, Adel Nefzi, PhD, Richard Houghten, PhD, Joseph Brandwein, MD, Mark D. Minden, MD, PhD, Andre Schuh, MD, PhD, Richard A. Wells, MD, PhD, Hans Messner, MD, PhD, John C. Reed, MD, PhD, Bing Z. Carter, PhD

Blood (2004) 104 (11): 759.

https://doi.org/10.1182/blood.V104.11.759.759

Published: 2004

Journal Articles

Functional Assessment of the Mitochondrial Pathway of Caspase Activation in Patients with Acute Myeloid Leukemia (AML).

Marcela Gronda, MSc, Joseph Brandwein, MD, Hans Messner, MD, PhD, Mark D. Minden, MD, PhD, Andre Schuh, MD, PhD, Richard A. Wells, MD, PhD, Aaron D. Schimmer, MD, PhD

Blood (2004) 104 (11): 2995.

https://doi.org/10.1182/blood.V104.11.2995.2995

Published: 2004

NARROW

Health-Related Quality of Life in Adults Treated with Blinatumomab Using the Acute Lymphoblastic Leukemia Symptom Scale

The Utility of Early Broncholaveolar Lavage in Prolonged Neutropenic Patients with Pulmonary Nodules

Migration in the Management of Philadelphia Positive ALL: Towards a Lower Risk of VTE

Azacitidine Has Limited Activity in Patients with MDS and AML

An Evaluation of Septicemia During Outpatient Consolidation Chemotherapy for Acute Myeloid Leukemia

A Phase I Study of ENMD-2076 In Patients with Relapsed or Refractory Leukemia

A Prognostic Score of Overall Survival In Adults with Acute Myeloid Leukemia

Validation of Monosomal Karyotype Based Model In the Risk Stratification of Acute Myeloid Leukemia

Low-Level FLT3-ITD Mutations Do Not Predict for Higher Relapse Rate in AML with Standard Risk Karyotpye.

Feasibility of Outpatient Consolidation Chemotherapy and Toxicity in Elderly Patients with AML.

Lack of Inhibition of AKT Predicts Clinical Resistance to Therapy with Imatinib + Reinduction Chemotherapy in Relapsed/Refractory c-Kit+ Acute Myeloid Leukemia.

Outcome of Patients Age 60 and Over with Acute Lymphoblastic Leukemia (ALL) Treated with a Modified Pediatric Protocol

A Phase I Trial of the Small Molecule Pan-Bcl-2 Family Inhibitor Obatoclax Mesylate (GX15-070) Administered by Continuous Infusion for up to Four Days to Patients with Hematological Malignancies.

A Phase I Trial of Two Sequence-Specific Schedules of Decitabine and Vorinostat in Patients with Acute Myeloid Leukemia (AML).

Nuclear Localization of the NuMA-RARα/RXRα Complex Is Necessary for Leukemogenesis in hCG-NuMA-RAR α Transgenic Mice.

Small-Molecule XIAP Inhibitors Derepress Downstream Effector Caspases and Induce Apoptosis of Leukemia Cell Lines and Patient Samples.

Functional Assessment of the Mitochondrial Pathway of Caspase Activation in Patients with Acute Myeloid Leukemia (AML).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only